abstract |
the present invention provides a composition for improving the sustained release capacity of n- (2-ethylsulfonylamino -5-trifluoromethyl -3-pyridyl) cyclohexanecarboxamide or a salt thereof. more specifically, the present invention provides a composition for topical administration comprising n- (2-ethylsulfonylamino -5-trifluoromethyl -3-pyridyl) cyclohexanecarboxamide or a salt thereof and a polycation polymer. |